BACE Inhibitors and Tau Protein Targeting Drugs in Prevention of Alzheimer's Disease [0.03%]
针对β分泌酶和tau蛋白的阿尔茨海默病预防药物研究进展
Jonathan Orf,Scot Walker
Jonathan Orf
Alzheimer's disease (AD) is a common disease in the United States with almost 10% of people older than 65 suffering from the disease. A few drugs provide some improvement in mental function in mild-to-moderate disease, but no treatments are...
Zaynah K Ali,Danial E Baker
Zaynah K Ali
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscrib...
Holly Phillips,Ivana Bogdanich,Kristen Carter et al.
Holly Phillips et al.
Response to Letter to the Editor on "Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options" [0.03%]
关于「酶替代或底物减少？一项关于戈谢病治疗选择的回顾」一文的回复信件
Alison Van Rossum,Megan Holsopple
Alison Van Rossum
Letter to the Editor on "Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options" [0.03%]
读者来信：“酶替代或底物减少？就戈谢病治疗选择的评论”的回应
Jennifer Ibrahim,Rebecca Call
Jennifer Ibrahim
In Reply to "Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital" [0.03%]
社区医院膝关节和髋关节置换术患者使用布比卡因脂质体术后镇痛的回复
Brian Faley,Lani Dvorak,Meghan Faley
Brian Faley
Knowing What Is Coming: The Importance of Monitoring the Pharmaceutical Pipeline [0.03%]
知彼预测药物研发进展的重要性
Scot Walker
Scot Walker
Daniel P O&#x;Neil,Lindsey Amerine,Carol Woodward
Daniel P O&#x;Neil
This article outlines challenges and solutions to new managers onboarding within a department of pharmacy. Keywords: ...
John D Hill,Thomas S Achey,Theresa A Nerone et al.
John D Hill et al.
Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags [0.03%]
普鲁卡因胺注射液在透明玻璃安瓿和聚氯乙烯袋中的稳定性研究
Ronald F Donnelly
Ronald F Donnelly
Objectives: The objective of this study was to evaluate the chemical stability of procainamide hydrochloride, 100 mg/mL, when repackaged in clear glass vials or diluted to 3 mg/mL with normal saline and packaged in polyvi...